endoscopic therapy; Presenting Author: MOHD. HARUN-OR- RASHID Additional Authors: AZRAFHOSSAIN KHAN, MD. AZIZUL HAQUE, MD. ZAHIRUL HAQUE, MD. KHALILUR RAHMAN, MOHAMMAD MAHBUBURRAHMAN KHAN, ABDUL ALIM, SALIMUR RAHMAN Corresponding Author: MOHD. HARUN-OR- RASHID Affiliations: Rajshahi Medical College; BSMMU Objective: The magnitude of liver diseases in Bangladesh is increasing gradually. Liver disease is one of the major issues causing morbidity and mortality. Cutaneous manifestions sometimes may be a clue to diagnose liver disease. To see the types and freequency of cutaneous manifestions in Chronic Liver Disease (CLD) this study was done. Methods: This was a Cross-sectionally designed clinico-epidemiological study.
Total 120 patients were included. Age of the patients ranges from 12 to 90 years. This study was conducted in Inpatient department LY2109761 mouse of Medicine at the Rajshahi Medical College Hospital over a period of 1 year (Aug 2011 to Aug 2012). All patients were admitted with the history or complaints of liver disease/disorders manifested with skin lesions. Diagnosis was made on the basis of history, examinations, bio-chemical tests, ultrasonography of abdomen & endoscopy. Results: There were Male 91 (75.8%) and Female 29 (24.2%). Mean age being 47.37 ± 15.07 years. Common etilogies were HBV 50 (41.7%), Alcohol 23 (19.2%), HCV 10 (8.3%) and others like NFLD, Arsenic, Cryptogenic etc. 37 (30.8%).
The affected peoples were low income groups, farmers and illiterates mostly. Isotretinoin Among the cutaneous findings- Hepatic selleck kinase inhibitor facies, Melanosis cutis, Scratch marks/Pruritus, Xerosis, Hypopigmentation, Spider angioma, Keratoderma, Bier’s spot, Dialated veins, Palmer erythema and Chrponic dermatitis were more prominent. Conclusion: The well known clinical signs & cutaneous manifestations of CLD remain valuable in the diagnosis of CLD which should be looked for patients with CLD purposively. Key Word(s): 1. Cutaneous; 2. Cutaneous markers; 3. Hepato-biliary; 4. Chronic
Liver; Presenting Author: HUA MAO Additional Authors: RUI LI Corresponding Author: HUA MAO Affiliations: Zhujiang hospital of Southern medical university Objective: Determination serum pepsinogen levels in liver cirrhosis patients, to investigate the function of gastric mucosa in liver cirrhosis. Methods: A total of 51 cirrhotic patients 22 healthy controls were studied by gastroscopy.51 cirrhotic patients were divided into PHG group and without PHG group according to gastroscope. Evaluated the hepatic function with Child-Pugh grade. Observed helicobacter pylori infection through rapid urease test or exhale carbon 13 experimental. At the same time, detected the serum pepsinogen I and II by latex-enhanced immunoturbidimetry, the PG I/PG II ratio (PGR) was calculated. Data were expressed as mean ± SD. Comparison between liver cirrhosis group and control group was performed by two-sample t-test. Comparison between three groups were performed by a standard one-way analysis of variance.